It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug...
http://www.fool.com.au/2015/03/12/heres-why-pharmaxis-ltd-shares-are-soaring-today/
NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients NICE Approves Pharmaxis' Bronchitol® As...
Pharmaxis Receives Approval to Market Bronchitol in the EU PR Newswire ELTVILLE, Germany, April 27, 2012 ELTVILLE, Germany, April 27, 2012...
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code J7665 mannitol administered through inhaler PR...
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit ARIDOL is the Only Dry Powder Bronchial Challenge...
Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, October 26, 2011 SYDNEY, October 26, 2011...
Pharmaceutical company Pharmaxis (ASX: PXS) today announced the Committee for Medicinal Products for Human Use (CHMP) has adopted...
Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, Oct. 24, 2011 SYDNEY, Oct. 24, 2011 /PRNewswire/...
The Committee for Medicinal Products for Human Use, or CHMP, said Friday that it has adopted positive opinions recommending the granting of...
Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness First...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads